Kevin Boyle, Alaunos Therapeutics CEO
January 27, 2022 10:30 AM EST
Pharma

Zio­pharm re­brands to Alaunos, clos­es Boston of­fice with new CEO at the reins

Max Gelman

Senior Editor

A lit­tle over a year af­ter fac­ing an ac­tivist at­tack that saw for­mer CEO Lau­rence Coop­er sur­vive but re­tire a few months lat­er, Zio­pharm On­col­o­gy …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times